Zhejiang Xianju Pharmaceutical Co.,Ltd.

SZSE:002332 Stock Report

Market Cap: CN¥12.0b

Zhejiang Xianju PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 6/6

Zhejiang Xianju PharmaceuticalLtd has a total shareholder equity of CN¥6.1B and total debt of CN¥101.2M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are CN¥6.9B and CN¥839.2M respectively. Zhejiang Xianju PharmaceuticalLtd's EBIT is CN¥680.4M making its interest coverage ratio -20.3. It has cash and short-term investments of CN¥1.3B.

Key information

1.7%

Debt to equity ratio

CN¥101.24m

Debt

Interest coverage ratio-20.3x
CashCN¥1.30b
EquityCN¥6.07b
Total liabilitiesCN¥839.16m
Total assetsCN¥6.91b

Recent financial health updates

Recent updates

Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Seems To Use Debt Quite Sensibly

Oct 16
Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Seems To Use Debt Quite Sensibly

A Look At The Intrinsic Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

Sep 03
A Look At The Intrinsic Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30

Jun 02
Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30

Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

Apr 15
Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding

Mar 05
There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding

Financial Position Analysis

Short Term Liabilities: 002332's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥737.7M).

Long Term Liabilities: 002332's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥101.4M).


Debt to Equity History and Analysis

Debt Level: 002332 has more cash than its total debt.

Reducing Debt: 002332's debt to equity ratio has reduced from 63.7% to 1.7% over the past 5 years.

Debt Coverage: 002332's debt is well covered by operating cash flow (319.8%).

Interest Coverage: 002332 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies